At Teal Ventures, we focus on being the lead investor exploiting funding gaps in early-stage venture.

 

Sector

  • Digital technology

  • Data Science

  • Medical devices

  • Software-as-a-Service

  • Rapid Path Pharma

Stage

  • Angel/Seed/Series A

  • Maximum 3-5 years to commercialization or exit

  • Co-investment with

    incubators, angel groups

    and other professional

    investors

Geography

  • Southern California

  • Northern California

  • Boston / Cambridge

  • Selectively in other US

    locations

Investment Type

  • Balanced mix of return and risk profiles

  • Equity, convertible debt

  • The Fund has a target portfolio composition of 50% women-founded or women-led companies